RM-041

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameRM-041
Drug Alias NameRM-041
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G13C inhibitors
TargetsKRAS G13C
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States Minor Outlying Islands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevolution Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesRevolution Medicines Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A